For filings with the FSA include the annex
For filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:ii Finsbury World Wide Pharmaceutical Trust
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result
in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to
qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify): Increase in Total Voting Rights following final conversion X
of warrants
3. Full name of person(s) subject to the Rensburg Sheppards Investment Management Limited
notification obligation:iii
4. Full name of shareholder(s) N/A
(if different from 3.):iv
5. Date of the transaction and date on 5th August 2009
which the threshold is crossed or
reached: v
6. Date on which issuer notified: 7th August 2009
7. Threshold(s) that is/are crossed or 5%
reached: vi, vii
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of Situation previous Resulting situation after the triggering transaction
shares to the triggering
transaction
if possible Number Number Number Number of voting % of voting rights x
using of of of shares rights
the ISIN CODE Shares Voting
Rights Direct Direct xi Indirect Direct Indirect
xii
Ordinary Shares
2,910,927 2,910,927 2,871,131 5.84%
GB0003385308
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date xiii Conversion Period xiv rights that may be rights
acquired if the
instrument is
exercised/ converted.
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial Exercise Expiration Exercise/ Number of voting rights % of voting rights
instrument price date xvii Conversion instrument refers to xix, xx
period xviii
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
2,871,131 5.84%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
Client holdings registered in the name of Nominee companies 100% owned by
Rensburg Sheppards Investment Management Limited.
Proxy Voting:
10. Name of the proxy holder:
N/A
11. Number of voting rights proxy holder will cease
to hold:
N/A
12. Date on which proxy holder will cease to hold
voting rights:
N/A
13. Additional information:
N/A
14. Contact name:
N/A
15. Contact telephone number:
N/A
Note: Annex should only be submitted to the FSA not the issuer
Annex: Notification of major interests in sharesxxii
A: Identity of the persons or legal entity subject to the notification
obligation
Full name Rensburg Sheppards Investment Management
Limited
(including legal form of legal entities)
Contact address Quayside House
(registered office for legal entities) Canal Wharf
Leeds LS11 5PU
Phone number & email 0113 236 4171
mike.rigby@rsim.co.uk
Other useful information Mike Rigby
(at least legal representative for legal (Head of Compliance)
persons)
B: Identity of the notifier, if applicable
Full name Philip Martin Beardwell
Contact address 2 Gresham Street
London
EC2V 7QN
Phone number & email 020 7597 1356
phil.beardwell@rsim.co.uk
Other useful information Senior Compliance Manager
(e.g. functional relationship with the
person or legal entity subject to the
notification obligation)
C: Additional information
For notes on how to complete form TR-1 please see the FSA website.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.